Price
$5.69-56.60%Social Signal Score
Analyst Ratings
12 analystsRevenue
$745.65M+1009.02%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Suzanne Foster
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 10,900
- Beta
- 1.36
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 0.38
Financials
Revenue
$745.65M+1009.0%Net Income
$-153.99M-69988.3%EBITDA
$-39.02M-503.0%Free Cash Flow
$51.06M+518.7%EPS (diluted)
$-1.13-16015.5%Shares Outstanding (diluted)
136.40M+336.5%Operating Expenses
$88.66MCash & Debt
$80.69MReturn of Capital
$0.00Revenue by Segment (annual)
$691.16MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.24B | $-70.79M | $-0.52 |
| 2024 | $3.26B | $90.42M | $0.62 |
| 2023 | $3.20B | $-678.89M | $-5.32 |
| 2022 | $2.97B | $69.32M | $0.52 |
| 2021 | $2.45B | $156.18M | $1.12 |
| 2020 | $1.06B | $-161.63M | $-1.23 |
| 2019 | $529.64M | $-21.34M | $-0.29 |
| 2018 | $345.28M | $2.09M | $0.07 |
| 2017 | $192.56M | $-693.00 | $-0.00 |
| 2016 | $174.32M | $-3.79M | $-0.12 |
Valuation
AHCOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70+133.33%Social Signal Score
Mentions (8)
- Newsseekingalpha.com·12d ago·Positive
AdaptHealth Corp. (AHCO) Presents at 2026 UBS Global Healthcare Conference Transcript AdaptHealth Corp. ( AHCO ) 2026 UBS Global Healthcare Conference November 10, 2026 2:45 PM EST Company Participants Suzanne Foster - CEO & Director Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good afternoon, everybody. Welcome, Day 2 UBS Healthcare Conference.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
AdaptHealth Corp. (AHCO) Q3 2026 Earnings Call Transcript AdaptHealth Corp. (AHCO) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·19d ago·Neutral
What AdaptHealth (AHCO) Said on Its Q3 Earnings Call AdaptHealth NASDAQ: AHCO reported third-quarter results that exceeded its revenue and adjusted EBITDA guidance, citing improving performance in its largest capitated contract, continued organic growth in its base business and tighter cost controls.
View source ↗ - Newsbusinesswire.com·72d ago·Negative
AdaptHealth To Participate in Upcoming Investor Conferences PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences: The 2026 Jefferies Healthcare Services and Technology Conference, being he…
View source ↗ - Newsglobenewswire.com·100d ago·Neutral
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information CONSHOHOCKEN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the AdaptHealth Corp. (Nasdaq: AHCO) data breach.
View source ↗ - Newsmarketbeat.com·103d ago·Negative
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth AdaptHealth NASDAQ: AHCO executives outlined the company's second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion.
View source ↗ - Newsfool.com·105d ago·Negative
Why AdaptHealth Stock Plummeted This Week AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The company also lowered its fiscal performance targets for the year.
View source ↗ - Newsbusinesswire.com·106d ago·Negative
AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $AHCO--AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law.
View source ↗
Earnings
Tue, Mar 2(in 3 months)
Consensus estimate $-0.04 per share
Typical surprise -64.5% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Nov 3$-0.18 vs $-0.05miss
- Tue, Aug 4$0.06 vs $0.17miss
- Tue, May 5$-0.06 vs $0.01miss
- Tue, Feb 24$0.27 vs $0.34miss
- Tue, Nov 4$0.22 vs $0.24miss
- Tue, Aug 5$0.01 vs $0.15miss
Estimates and results for AHCO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AHCO officers and directors.
- Bought
- $49.3m
- Sold
- $2.5m
16 trades
11 trades
- Wolf Dale Bbought
- Wolf Dale Bbought
- Samet Kenneth Abought
- Wolf Dale Bbought
- Schuster Iii Russell E.sold
- Schuster Iii Russell E.sold
- Oep Vii Gp, L.l.c.bought
- Cashin Richard M Jrbought
73 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Susie Leehouse · NV03 · disclosed Dec 29, 2022 (29d later)Sell$1,001 - $15,000
- Kevin Hernhouse · OK01 · disclosed May 12, 2022 (41d later)Sell$50,001 - $100,000
- Kevin Hernhouse · OK01 · disclosed May 12, 2022 (20d later)Sell$1,001 - $15,000
- Kevin Hernhouse · OK01 · disclosed Jun 15, 2021 (26d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Jun 14, 2021 (19d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Mar 11, 2021 (28d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Mar 11, 2021 (30d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Feb 10, 2021 (19d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Feb 10, 2021 (36d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
